Chetan Mukhtyar

May 22, 2024 | ard.bmj.com | Myrto Kostopoulou |Chetan Mukhtyar |George Bertsias |Dimitrios T. Boumpas

DiscussionFor the recent update of the EULAR recommendations for the management of SLE, we performed five different SLRs based on respective PICOs, to cover the most important aspects in the treatment of this challenging disease. HCQ is the backbone treatment for all patients with SLE, while GC are still used in the majority of patients. The current SLR confirmed the beneficial effects of HCQ in lupus, ranging from prevention of infections or thrombosis to improved survival.